You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CPD

Genetic Testing in Ovarian Cancer: Patient Impact and How to Handle These Difficult Scenarios

  • Authors: Jacob Korach, MD, MBA
  • CPD Released: 5/19/2022
  • Valid for credit through: 5/19/2023
Start Activity

  • Credits Available

    Non-US Physicians - maximum of 0.25 CPD

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This educational activity is intended for an international audience of obstetricians and gynecologists, hematology/oncology specialists, and pathologists.

 

The goal of this activity is for the learner to improve their ability on the use of appropriate genetic tests to guide treatment of ovarian cancer and determine the impact of genetic testing on the patient.

 

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Use of genetic tests to guide the management of patients with ovarian cancer
    • Adverse effects in patients treated with PARP maintenance therapy
  • Demonstrate greater confidence in their ability to
    • Discuss the results of genetic testing with patients with ovarian cancer


Disclosures

WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.


Faculty

  • Jacob Korach, MD, MBA

    Director
    Gynecology Oncology Department
    Sheba Medical Center
    Sackler School of Medicine
    Tel Aviv University
    Tel Aviv, Israel

    Disclosures

    Disclosure: Jacob Korach, MD, MBA, has no relevant financial relationships.

Editor

  • Mihai Surducan, PhD

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Mihai Surducan, PhD, has no relevant financial relationships.

Compliance Reviewer

  • Amanda Jett, PharmD, BCACP

    Associate Director, Accreditation and Compliance

    Disclosures

    Disclosure: Amanda Jett, PharmD, BCACP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements

    For Physicians

  • The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.25 continuing professional development credits (CPD).

    Contact WebMD Global

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information about your eligibility to claim credit, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online during the credit eligibility period that is noted on the title page.

Follow these steps to claim a credit certificate for completing this activity:

  1. Read the information provided on the title page regarding the target audience, learning objectives, and author disclosures, read and study the activity content and then complete the post-test questions. If you earn a passing score on the post-test and we have determined based on your registration profile that you may be eligible to claim CPD credit for completing this activity, we will issue you a CPD credit certificate.
  2. Once your CPD credit certificate has been issued, you may view and print the certificate from your CME/CE Tracker. CPD credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of the Medscape Education homepage.

We encourage you to complete an Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CPD

Genetic Testing in Ovarian Cancer: Patient Impact and How to Handle These Difficult Scenarios

Authors: Jacob Korach, MD, MBAFaculty and Disclosures

CPD Released: 5/19/2022

Valid for credit through: 5/19/2023

processing....

Medscape Clinic Patient Information

Patient Name: Abigail

Patient Age: 47 years

Presenting Condition: The patient presents with a mass on the left ovary, enlarged retroperitoneal lymph nodes (diameter of 2 cm) below the level of the renal veins, and small volume of ascites.

Abigail is a 47-year-old female with no major comorbidities, no personal history of cancer, who is perimenopausal. Prior investigations showed a mass on her left ovary during a routine gynecologic exam. Her CA-125 was 175 U/mL and a computerized tomography (CT) scan showed a 6 cm complex mass on the left ovary, enlarged retroperitoneal lymph nodes (diameter of 2 cm) below the level of the renal veins, and small volume of ascites. Abigail is presenting today to a medical oncologist’s office to determine if the mass is cancerous.

Please answer the questions that appear during the activity: Choose an answer, scroll down, and click “Submit.” See responses, scroll down, and click “Continue.”

 

 

Educational Impact Challenge

Play the video to start the activity. After completion, click Next to test how much you've learned.

  • Print